OCTANATE Trademark

Trademark Overview

On Wednesday, October 1, 2014, a trademark application was filed for OCTANATE with the United States Patent and Trademark Office. The USPTO has given the OCTANATE trademark a serial number of 79157292. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Saturday, December 2, 2017. This trademark is owned by Octapharma AG. The OCTANATE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, factor VIII preparations obtained from human blood plasma for prophylaxis and treatment of bleeding in patients with haemophilia A
octanate

General Information

Serial Number79157292
Word MarkOCTANATE
Filing DateWednesday, October 1, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSaturday, December 2, 2017
Registration Number4810650
Registration DateTuesday, September 15, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 30, 2015

Trademark Statements

Goods and ServicesPharmaceutical products, namely, factor VIII preparations obtained from human blood plasma for prophylaxis and treatment of bleeding in patients with haemophilia A

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateSaturday, December 2, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOctapharma AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameOctapharma AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameOctapharma AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Friday, June 15, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, June 15, 2018DEATH OF INTERNATIONAL REGISTRATION
Thursday, August 18, 2016NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 11, 2016NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 11, 2016NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 17, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, March 22, 2016FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, March 22, 2016FINAL DISPOSITION PROCESSED
Tuesday, December 15, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 15, 2015REGISTERED-PRINCIPAL REGISTER
Saturday, July 11, 2015NOTIFICATION PROCESSED BY IB
Tuesday, June 30, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2015PUBLISHED FOR OPPOSITION
Wednesday, June 24, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 24, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 10, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 26, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 26, 2015ASSIGNED TO LIE
Thursday, April 30, 2015EXAMINERS AMENDMENT MAILED
Thursday, April 30, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 30, 2015EXAMINER'S AMENDMENT ENTERED
Thursday, April 30, 2015EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 29, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 29, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 29, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 19, 2015REFUSAL PROCESSED BY IB
Tuesday, January 27, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 27, 2015REFUSAL PROCESSED BY MPU
Tuesday, January 27, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 26, 2015NON-FINAL ACTION WRITTEN
Wednesday, January 21, 2015ASSIGNED TO EXAMINER
Tuesday, December 30, 2014APPLICATION FILING RECEIPT MAILED
Wednesday, December 24, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 18, 2014SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

octanate prophylaxis plasma blood treatment bleeding haemophilia patients human from namely